Can Urinary PCA3 Supplement PSA in the Early Detection of Prostate Cancer?
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Can Urinary PCA3 Supplement PSA in the Early Detection of Prostate Cancer?
Authors
Keywords
-
Journal
JOURNAL OF CLINICAL ONCOLOGY
Volume 32, Issue 36, Pages 4066-4072
Publisher
American Society of Clinical Oncology (ASCO)
Online
2014-11-11
DOI
10.1200/jco.2013.52.8505
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Screening for Prostate Cancer: A Review of the Evidence for the U.S. Preventive Services Task Force
- (2013) Roger Chou et al. ANNALS OF INTERNAL MEDICINE
- Complications following prostate needle biopsy requiring hospital admission or emergency department visits - experience from 1000 consecutive cases
- (2012) G. Igor Pinkhasov et al. BJU INTERNATIONAL
- Cancer statistics, 2012
- (2012) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Screening for Prostate Cancer With Prostate-Specific Antigen Testing: American Society of Clinical Oncology Provisional Clinical Opinion
- (2012) Ethan Basch et al. JOURNAL OF CLINICAL ONCOLOGY
- PCA3 sensitivity and specificity for prostate cancer detection in patients with abnormal PSA and/or suspicious digital rectal examination. First Latin American experience
- (2012) Christian G. Ramos et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- A Multicenter Study of [-2]Pro-Prostate Specific Antigen Combined With Prostate Specific Antigen and Free Prostate Specific Antigen for Prostate Cancer Detection in the 2.0 to 10.0 ng/ml Prostate Specific Antigen Range
- (2011) William J. Catalona et al. JOURNAL OF UROLOGY
- Morbidity Of Prostate Biopsy After Simplified Versus Complex Preparation Protocols: Assessment of Risk Factors
- (2011) Osama M. Zaytoun et al. UROLOGY
- Biopsy and treatment decisions in the initial management of prostate cancer and the role of PCA3; a systematic analysis of expert opinion
- (2011) Bertrand Tombal et al. WORLD JOURNAL OF UROLOGY
- A Prospective, Multicenter, National Cancer Institute Early Detection Research Network Study of [-2]proPSA: Improving Prostate Cancer Detection and Correlating with Cancer Aggressiveness
- (2010) L. J. Sokoll et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- PCA3: From basic molecular science to the clinical lab
- (2010) John R. Day et al. CANCER LETTERS
- Rational approach to implementation of prostate cancer antigen 3 into clinical care
- (2009) Rou Wang et al. CANCER
- Validation in a Multiple Urology Practice Cohort of the Prostate Cancer Prevention Trial Calculator for Predicting Prostate Cancer Detection
- (2009) Stephen J. Eyre et al. JOURNAL OF UROLOGY
- Prostate Specific Antigen Best Practice Statement: 2009 Update
- (2009) Kirsten L. Greene et al. JOURNAL OF UROLOGY
- Mortality Results from a Randomized Prostate-Cancer Screening Trial
- (2009) Gerald L. Andriole et al. NEW ENGLAND JOURNAL OF MEDICINE
- Screening and Prostate-Cancer Mortality in a Randomized European Study
- (2009) Fritz H. Schröder et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clinical Utility of the PCA3 Urine Assay in European Men Scheduled for Repeat Biopsy
- (2008) Alexander Haese et al. EUROPEAN UROLOGY
- PCA3 Molecular Urine Assay Correlates With Prostate Cancer Tumor Volume: Implication in Selecting Candidates for Active Surveillance
- (2008) Hiroyuki Nakanishi et al. JOURNAL OF UROLOGY
- PCA3: A Molecular Urine Assay for Predicting Prostate Biopsy Outcome
- (2008) Ina L. Deras et al. JOURNAL OF UROLOGY
- Conditional estimation of sensitivity and specificity from a phase 2 biomarker study allowing early termination for futility
- (2008) Margaret Sullivan Pepe et al. STATISTICS IN MEDICINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now